Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
30 April 2024 - E1274
The platform trial in COVID-19 priming and boosting (PICOBOO): the immunogenicity, reactogenicity, and safety of three approved COVID-19 booster vaccines in immunocompetent adults
Charlie Mcleod, Michael Dymock, Katie Flanagan, Plebanski Magdalena, Helen Marshall, Marie Estcourt, Jessica Ramsay, Ushma Wadia, Christian Tjiam, Christopher Blyth, Kanta Subbarao, Suellen Nicholson, Saul Faust, Thornton Ruth, Mckenzie Anne, Snelling Tom, Richmond Peter,
29 April 2024 - P1816
In vitro activity of sulbactam/durlobactam in combination with cefepime against Gram-negative bacterial isolates from a recent Phase 3 clinical trial
Sarah Mcleod, Dana Dressel, Meredith Hackel, Alita Miller
28 April 2024 - P2527
Antimicrobial susceptibility of baseline Neisseria gonorrhoeae isolates from participants recruited in the global zoliflodacin Phase 3 randomised controlled trial
Alison Luckey, Varalakshmi Elango, Esther Bettiol, Laura J. V. Piddock, Magnus Unemo, Patricia Bradford, Sarah Mcleod, John P. Mueller, Subasree Srinivasan
17 April 2023 - P2126
In vitro susceptibility of Acinetobacter baumannii-calcoaceticus complex (ABC) to sulbactam-durlobactam in combination with a carbapenem
Sarah Mcleod, Nicole Carter, Alita Miller
17 April 2023 - P2256
Three outbreaks of colistin-resistant (COL-R) Acinetobacter baumannii infections in Eastern Europe during ATTACK (a recent Phase 3 study) were effectively treated with sulbactam-durlobactam
Samir Moussa, Sarah Mcleod, Khurram Rana, David Altarac, Alita Miller
16 April 2023 - P1378
Racial differences in the treatment of urinary tract infections in the outpatient setting
Caleb Mcleod, Sasha Rodriguez, Hadeel Al-Fayiz, Karen Tan, Jacinda Abdul-Mutakabbir
26 April 2022 - O0817
Efficacy and safety of sulbactam-durlobactam (SUL-DUR) versus colistin therapy in patients with Acinetobacter baumannii-calcoaceticus complex (ABC) infections: a global, randomised, active-controlled phase III trial (ATTACK)
David Altarac, Robin Isaacs, Subasree Srinivasan, Sarah Mcleod, Khurram Rana, Gabrielle Poirier, Andrew Shorr, Keith Kaye
25 April 2022 - O0646
Performances of ICT toxoplasma IgG-IgM test in comparison with vidas toxo competition to determine the immune status of patients against Toxoplasma gondii
Sylvie Abraham, Rima Mcleod, Nadhira Houhou-Fidouh, Raphaël Piarroux, Pascale Niçaise-Rolland, Luce Landraud, Sandrine Houze
24 April 2022 - O0517
Characterisation of Acinetobacter baumannii-calcoaceticus complex (ABC) pathogens isolated at baseline from patients enrolled in the ATTACK phase III trial
Alita Miller, Sarah Mcleod, Daria Chabas, Gabrielle Poirier, David Altarac
23 April 2022 - P0915
Characterisation of co-infecting Gram-negative pathogens isolated in addition to Acinetobacter baumannii-calcoaceticus complex (ABC) at baseline from patients enrolled in the ATTACK phase III trial
Alita Miller, Sarah Mcleod, Daria Chabas, Gabrielle Poirier, David Altarac
23 April 2022 - P0463
Characterising the anaerobic organisms unidentified by a commercial blood culture nucleic acid test
Karen Tan, Caleb Mcleod, Kenneth Nguyen, Anna Zhou, Jacinda Abdul-Mutakabbir
23 April 2022 - P1397
Efficacy and safety of sulbactam-durlobactam (SUL-DUR) therapy in patients with Acinetobacter baumannii-calcoaceticus complex (ABC) infections in the open label part B of the ATTACK phase III trial
David Altarac, Robin Isaacs, Subasree Srinivasan, Sarah Mcleod, Khurram Rana, Gabrielle Poirier, Andrew Shorr, Keith Kaye
09 July 2021 - 1522
In vitro activity of sulbactam/durlobactam against recent global clinical Acinetobacter baumannii-calcoaceticus complex isolates
Sarah Mcleod, S. Mcleod (1), S. Moussa (1), M. Hackel (2), A. Miller (1)
14 April 2019 - P1185
The novel beta-lactamase inhibitor ETX2514 effectively restores sulbactam activity against recent global Acinetobacter baumannii-calcoaceticus complex clinical isolates
Sarah McLeod, Samir Moussa, Meredith Hackel, Ruben Tommasi, Alita Miller
14 April 2019 - P1184
The novel beta-lactamase inhibitor ETX1317 effectively restores the activity of cefpodoxime against recent global Enterobacteriaceae isolates from urinary tract infections
Sarah McLeod, Samir Moussa, Michael Huband, Yahse Edah, Ruben Tommasi, John Mueller, Alita Miller
14 April 2019 - O0527
Discovery of a novel series of penicillin-binding protein 3 inhibitors as monotherapy for Pseudomonas aeruginosa infections: rational design of biochemical potency and bacterial permeation
Thomas Durand-Reville, Xiaoyun Wu, Satenig Guler, Jing Zhang, Janelle Comita-Prevoir, Mark Sylvester, Jan Romero, Camilo Velez-Vega, Frank Wu, Ramkumar Iyer, Adam Shapiro, Samir Moussa, Nicole Carter, April Chen, Angela Tanudra, Sarah McLeod, Alita Miller, John O'Donnell, Ruben Tommasi
23 April 2018 - O0679
Evaluation of three point-of-care (POC) tests for detection of Toxoplasma-IgG and IgM in the United States: proof of concept and pitfalls
Jose G. Montoya, C. Gomez, L. Budvytyte, C. Press, R. McLeod, Y. Maldonado, J. Montoya, D. Contopoulos-Ioannidis
11 April 2016 - P1332
Availability of guidance, decision support tools and education to enable appropriate antimicrobial prescribing in English primary care settings
Emma Budd, Budd Emma, Paukner Susanne, E. Budd, C. McNulty, E. Beech, A. Bhattacharya, M. McLeod, D. Ashiru-Oredope
26 April 2015 - P0418
mHealth: investigating the need for an evidence-based antimicrobial stewardship application for patients
Christianne Micallef, McLeod, Monsey; Micallef, Christianne*; Gharbi, Myriam; Gilchrist, Mark; Charani, Esmita; Moore, Luke SP; Castro-Sanchez, Enrique; Holmes, Alison H;
10 May 2014 - eP538
Mobile device applications for antimicrobial stewardship – is there a role in primary care? Preliminary findings from a survey of general practitioners in the United Kingdom
Monsey McLeod, McLeod, M.(1)*; Charani, E.(1); Castro-Sanchez, E.(1); Moore, L.S.P.(1); Gharbi, M.(1); Gilchrist, M.(2); Holmes, A.(1);
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.